Clinuvel Pharmaceuticals (UR9.MU) Q1 2026 Earnings

25FebConfirmed
Q1 2026
0.12
0.13
0.15
0.17

Details

Expected EPS
0.16525896168235998
Actual EPS
0.11651557666699999
Surprise EPS
-0.05
Surprise Percent
+29.5%

Description

Clinuvel Pharmaceuticals (UR9.MU) has reported earnings of 0.11651557666699999 per share for Q1 2026.

0 Comments

Share your thoughts